Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reassessing B cell contributions in multiple sclerosis
Rui Li, Kristina R. Patterson, Amit Bar‐Or
Nature Immunology (2018) Vol. 19, Iss. 7, pp. 696-707
Closed Access | Times Cited: 329

Showing 1-25 of 329 citing articles:

Multiple sclerosis
Massimo Filippi, Amit Bar‐Or, Fredrik Piehl, et al.
Nature Reviews Disease Primers (2018) Vol. 4, Iss. 1
Closed Access | Times Cited: 1054
Treatment of Multiple Sclerosis: A Review
Stephen L. Hauser, Bruce Cree
The American Journal of Medicine (2020) Vol. 133, Iss. 12, pp. 1380-1390.e2
Open Access | Times Cited: 643
Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis
Hans Lassmann
Frontiers in Immunology (2019) Vol. 9
Open Access | Times Cited: 547
B cell depletion therapies in autoimmune disease: advances and mechanistic insights
Dennis S. W. Lee, Olga L. Rojas, Jennifer L. Gommerman
Nature Reviews Drug Discovery (2020) Vol. 20, Iss. 3, pp. 179-199
Open Access | Times Cited: 462
Immune cell regulation of glia during CNS injury and disease
Andrew D. Greenhalgh, Sam David, F. Chris Bennett
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 3, pp. 139-152
Closed Access | Times Cited: 307
B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma
Johannes Griss, Wolfgang Bauer, Christine Wagner, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 303
B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers
Jamie van Langelaar, Liza Rijvers, Joost Smolders, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 229
Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies
Amit Bar‐Or, Michael P. Pender, Rajiv Khanna, et al.
Trends in Molecular Medicine (2019) Vol. 26, Iss. 3, pp. 296-310
Open Access | Times Cited: 226
Bacteroides fragilis polysaccharide A induces IL-10 secreting B and T cells that prevent viral encephalitis
Chandran Ramakrishna, Maciej Kujawski, Hiutung Chu, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 225
The Immune Response in Multiple Sclerosis
Sofía Rodríguez Murúa, Mauricio Farez, Francisco J. Quintana
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 17, Iss. 1, pp. 121-139
Closed Access | Times Cited: 216
Role of B Cells in Multiple Sclerosis and Related Disorders
Gıancarlo Comı, Amit Bar‐Or, Hans Lassmann, et al.
Annals of Neurology (2020) Vol. 89, Iss. 1, pp. 13-23
Open Access | Times Cited: 194
B cells in multiple sclerosis — from targeted depletion to immune reconstitution therapies
Maria Teresa Cencioni, Miriam Mattoscio, Roberta Magliozzi, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 7, pp. 399-414
Closed Access | Times Cited: 176
Rituximab for the treatment of multiple sclerosis: a review
Clara Grazia Chisari, Eleonora Sgarlata, Sebastiano Arena, et al.
Journal of Neurology (2021) Vol. 269, Iss. 1, pp. 159-183
Open Access | Times Cited: 153
Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances
Amit Bar‐Or, Rui Li
The Lancet Neurology (2021) Vol. 20, Iss. 6, pp. 470-483
Closed Access | Times Cited: 151
Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting
Marc Charabati, Michael A. Wheeler, Howard L. Weiner, et al.
Cell (2023) Vol. 186, Iss. 7, pp. 1309-1327
Open Access | Times Cited: 119
B cells in central nervous system disease: diversity, locations and pathophysiology
Rajiv W. Jain, V. Wee Yong
Nature reviews. Immunology (2021) Vol. 22, Iss. 8, pp. 513-524
Open Access | Times Cited: 105
Age-associated B cells in autoimmune diseases
Isobel C. Mouat, Erin J. Goldberg, Marc S. Horwitz
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 8
Open Access | Times Cited: 101
Bruton tyrosine kinase inhibitors for multiple sclerosis
Julia Krämer, Amit Bar‐Or, Timothy J. Turner, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 5, pp. 289-304
Open Access | Times Cited: 99
The Role of Viral Infections in the Onset of Autoimmune Diseases
Bhargavi Sundaresan, Fatemeh Shirafkan, Kevin Ripperger, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 782-782
Open Access | Times Cited: 87
Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target
Rongzeng Liu, Shushu Du, Lili Zhao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 79
Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy
Francesca Aloisi, Gavin Giovannoni, Marco Salvetti
The Lancet Neurology (2023) Vol. 22, Iss. 4, pp. 338-349
Closed Access | Times Cited: 72
Roles and regulation of microglia activity in multiple sclerosis: insights from animal models
Félix Distéfano‐Gagné, Sara Bitarafan, Steve Lacroix, et al.
Nature reviews. Neuroscience (2023) Vol. 24, Iss. 7, pp. 397-415
Closed Access | Times Cited: 54
An autoantibody signature predictive for multiple sclerosis
Colin R. Zamecnik, Gavin M. Sowa, Ahmed Abdelhak, et al.
Nature Medicine (2024) Vol. 30, Iss. 5, pp. 1300-1308
Closed Access | Times Cited: 31
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis
Massimiliano Calabrese, Paolo Preziosa, Antonio Scalfari, et al.
Annals of Neurology (2024) Vol. 96, Iss. 1, pp. 1-20
Open Access | Times Cited: 28
Immunological Aspects of Approved MS Therapeutics
Paulus Rommer, Ron Milo, May Han, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 137
Page 1 - Next Page

Scroll to top